Skip navigation
Header
Logo of the University of Zurich, to homepage
Search
Open/Close Navigation
URPP ITINERARE
Quicklinks
Home
Contact
Search
Main navigation
About us
Zurück
About us
About us
Menü schliessen
Research
Zurück
Research
Research
Menü schliessen
Events
Zurück
Events
Events
Menü schliessen
Educational and Training Programs
Zurück
Educational and Training Programs
Educational and Training Programs
Menü schliessen
News
Zurück
News
News
Menü schliessen
Publications
Zurück
Publications
Publications
Menü schliessen
More
Menü schliessen
Home
Research
ITINERARE Junior Grants
ITINERARE Junior Grants 2022
Show Subpages
Vanishing White Matter Disease
Remethylation Disorders
Rare endolysosomal disorders
Stakeholders in rare disease health care
Unterseiten-Menü schliessen
ITINERARE Junior Grants 2022
Grid containing content elements
Therapeutic use of CRISPR/Cas9 base editing for the treatment of Vanishing White Matter Disease
More about Therapeutic use of CRISPR/Cas9 base editing for the treatment of Vanishing White Matter Disease
Epigenetic changes in remethylation disorders: a novel target
More about Epigenetic changes in remethylation disorders: a novel target
An integrated drug discovery strategy for rare endolysosomal disorders
More about An integrated drug discovery strategy for rare endolysosomal disorders
Bridging the gap between stakeholders in rare disease health care. A qualitative focus group study
More about Bridging the gap between stakeholders in rare disease health care. A qualitative focus group study
Vanishing White Matter Disease
Remethylation Disorders
Rare endolysosomal disorders
Stakeholders in rare disease health care
.jpg)